Add Formweb to your mobile device
Search results for:
vedolizumab
vedolizumab
Brand names: Entyvio, Entyvio Pen
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 300 mg | Restricted to use in the outpatient setting to patients with Ulcerative Colitis & Crohn's Disease | ||||||||||
| SOLUTION, SUBCUTANEOUS | 108 mg/0.68 mL | NON FORMULARY |
Last updated: Jan. 25, 2024
- Restricted: vedolizumab (Entyvio) is restricted to use in the Outpatient setting to patients with Ulcerative colitis & Crohn's Disease
- CMS Self-Administered Drug Exclusion List Entyvio (subcutaneous only)